New tech, new talent, new challenges – pharma leadership in the age of AI

Despite great hopes for Artificial Intelligence (AI) in biotech and
pharma—with investments exceeding $50 billion over the past ten
years—the question of when the technology will reach maturity
remains difficult to answer. How can biotech and pharma leaders
navigate this complex gray area, where hype around the technology
obscures the outlook and few concrete milestones provide clear
signposts for decision-making? In this episode of the BioRevolution
podcast, Louise von Stechow and Andreas Horchler speak with their
guest, idalab founder Paul von Bünau, about the potential of AI in
biotech. They explore how leaders can adapt internal processes,
support their teams in facing the challenges AI brings, and examine
whether AI has the potential to make us better leaders. Find Dr.
Paul von Bünau here: https://www.linkedin.com/in/paulvonbuenau/ and
idalab here: https://idalab.de/ Disclaimer: Louise von Stechow
& Andreas Horchler and their guests express their personal
opinions, which are founded on research on the respective topics,
but do not claim to give medical, investment or even life advice in
the podcast. Learn more about the future of biotech in our podcasts
and keynotes. Contact us here: scientific communication:
https://science-tales.com/ Podcasts: https://www.podcon.de/
Keynotes: https://www.zukunftsinstitut.de/louise-von-stechow Image:
Matteo Vistocco via Unsplash